Zahra Bahadoran
Overview
Explore the profile of Zahra Bahadoran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
148
Citations
1914
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bahadoran Z, Kashani Z, Mahdavi M, Mirmiran P, Azizi F
Eur J Med Res
. 2025 Feb;
30(1):110.
PMID: 39962610
Background And Aim: This cohort study investigated the potential association between dietary fat intakes and returning to normal glucose regulation (NGR) in different prediabetes (Pre-DM) phenotypes. Methods: A total of...
2.
Bahadoran Z, Mirmiran P, Ghasemi A, Azizi F
Clin Hypertens
. 2025 Feb;
31:e4.
PMID: 39944940
Background: This cross-sectional study investigated the multi-stage and phenotype-specific association between urine-estimated salt intake and hypertension (HTN) in the Tehran Lipid and Glucose Study. Methods: Adult participants ( = 1,782,...
3.
Bahadoran Z, Ghafouri-Taleghani F, Azizi F, Ghasemi A
Biol Trace Elem Res
. 2025 Feb;
PMID: 39939554
This cohort study investigated the possible association between serum zinc (SZn) concentration and the risk of progression to type 2 diabetes (T2D) in subjects with isolated impaired glucose tolerance (iIGT)....
4.
Bahadoran Z, Mirmiran P, Kashfi K, Ghasemi A
Eat Weight Disord
. 2024 Dec;
29(1):77.
PMID: 39719521
Time-restricted feeding (TRF), an intermittent fasting approach involving a shortened eating window within 24 h, has gained popularity as a weight management approach. This review addresses how TRF may favor...
5.
Bahadoran Z, Mirmiran P, Ghasemi A, Azizi F
J Diabetes Metab Disord
. 2024 Dec;
24(1):8.
PMID: 39697867
Objectives: This cohort study investigated the possible association of dietary nitrate (NO)/nitrite (NO) intake and risk of progression to type 2 diabetes (T2D) across different phenotypes of prediabetes (Pre-DM). Methods:...
6.
Bahadoran Z, Mirmiran P, Ghasemi A
Nutr Metab (Lond)
. 2024 Dec;
21(1):107.
PMID: 39695784
Sarcopenia, characterized by progressive and generalized loss of skeletal muscle (SkM) mass, strength, and physical performance, is a prevalent complication in type 2 diabetes (T2D). Nitric oxide (NO), a multifunctional...
7.
Rezaeizadeh F, Ghazbani A, Nouri M, Bahadoran Z, Mansourzadeh M, Khalili D
J Diabetes Metab Disord
. 2024 Nov;
23(2):2417.
PMID: 39610550
[This corrects the article DOI: 10.1007/s40200-024-01392-9.].
8.
Masumi M, Bahadoran Z, Mirmiran P, Khalili D, Sarvghadi F, Azizi F
BMC Public Health
. 2024 Nov;
24(1):3143.
PMID: 39533278
Aim: We assessed the impact of a 3-year change-percent in adiposity measures on regression and pre-diabetes (Pre-DM) progression among Iranian adults. Methods: Three-year change-percent in body weight (BW), body mass...
9.
Bahadoran Z, Mirmiran P, Azizi F
Sci Rep
. 2024 Nov;
14(1):27577.
PMID: 39528808
This cross-sectional study investigated the associations between urinary sodium (UNa) to potassium (UK) ratio, different phenotypes of elevated blood pressure (BP), and microalbuminuria (MAU) in a cohort of the Tehran...
10.
Kokabeh F, Bahadoran Z, Mahdavi M, Valizadeh M, Barzin M, Azizi F, et al.
Nutr Metab Cardiovasc Dis
. 2024 Oct;
35(1):103755.
PMID: 39448315
Background And Aim: Our aim was risk estimation for cardiovascular disease (CVD) across obesity phenotypes over 18 years of follow-up using both time-invariant and time-varying approaches. Methods And Results: This...